Best treatments for coronary artery disease
19 products may treat coronary artery disease, spanning FDA drug classes such as calcium channel blocker, dihydropyridine calcium channel blocker, hmg-coa reductase inhibitor. The current highest-rated option is amlodipine besylate. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 19 drugs we list for coronary artery disease, 18 are available as lower-cost generics, spanning classes such as calcium channel blocker, dihydropyridine calcium channel blocker, hmg-coa reductase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for coronary artery disease — so confirm the right choice with your prescriber.
Understanding coronary artery disease
Coronary artery disease (CAD) is, in the words of MedlinePlus (NLM), "the most common type of heart disease" — the arteries supplying the heart muscle harden and narrow as cholesterol and other material, called plaque, build up on their inner walls. StatPearls (NCBI Bookshelf) puts a number on the narrowing that matters: "Coronary flow reduction starts with stenosis exceeding 50% and accelerates once it surpasses 70%" — which is why a report of a mild plaque and a report of a tight lesion are two different conversations. What people get wrong is assuming CAD announces itself. StatPearls notes that stable ischemic heart disease "may be completely asymptomatic," and that the underlying atherosclerosis "starts in childhood and develops over decades, during which patients are completely asymptomatic." The NHLBI likewise says coronary heart disease is sometimes "silent," meaning "you may not have any symptoms until you have a heart attack or other complication," and that about 1 in 20 adults aged 20 and older have coronary heart disease. NHLBI also notes that women are somewhat less likely than men to experience chest pain with a heart attack, and more likely to experience dizziness, extreme tiredness, nausea, and stomach pain. This page is general information, not medical advice — decisions about testing or treatment belong with your own clinician.
First-line treatment
For chronic (stable) coronary disease, the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline treats medication and lifestyle — not stents — as the foundation. Lipid lowering leads: "Aggressive lowering of LDL-C remains a pillar of CCD management," with statins first and non-statin agents such as PCSK9 inhibitors added when targets are missed. Antiplatelet cover is usually single-agent low-dose aspirin. The guideline also recommends SGLT2 inhibitors and GLP-1 receptor agonists for selected patients "even in those without diabetes," and narrows long-term beta-blocker use to specific indications (reduced ejection fraction, angina, arrhythmia, hypertension). The counterintuitive part: trials including COURAGE and ISCHEMIA showed "routine revascularization did not necessarily decrease MACE rates" beyond optimal medical therapy.
Top-rated picks for coronary artery disease: 1. Amlodipine Besylate · 2. Crestor · 3. Gemfibrozil
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | Calcium Channel Blocker | Generic | $0 | View → | |
| 2 | 70/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $1 | View → | |
| 3 | 70/100 | Prescription | Tablet | Peroxisome Proliferator Receptor alpha Agonist | Generic | $3 | View → | |
| 4 | 70/100 | Prescription | Suspension | — | No data | — | View → | |
| 5 | 70/100 | Prescription | Tablet | Calcium Channel Blocker | Generic | $0 | View → | |
| 6 | 70/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $1 | View → | |
| 7 | 68/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $86 | View → | |
| 8 | 66/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 9 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 10 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → |
Narrow by drug class
Explore the class hubs: hmg-coa reductase inhibitor · calcium channel blocker · bile acid sequestrant · peroxisome proliferator receptor alpha agonist
Full ranking · 19 treatments
amlodipine besylate
PrescriptionFDA-sourced
Amlodipine Besylate is a calcium channel blocker used to treat Variant Angina Pectoris, Coronary Artery Disease, Hypertension.
Pharmacy pays
From ~$0.31/30· 3 formscrestor
PrescriptionFDA-sourced
Crestor (Rosuvastatin Calcium) is a HMG-CoA reductase inhibitor used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$1.04/30· 4 forms Save up to 32% in classgemfibrozil
PrescriptionFDA-sourced
Gemfibrozil is a peroxisome proliferator receptor alpha agonist used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
~$3.09 /30
Save up to 10% in classkaterzia
PrescriptionFDA-sourced
Katerzia (Amlodipine Benzoate) is a medication used to treat Variant Angina Pectoris, Coronary Artery Disease, Hypertension.
Price varies
norvasc
PrescriptionFDA-sourced
Norvasc (Amlodipine Besylate) is a calcium channel blocker used to treat Variant Angina Pectoris, Coronary Artery Disease, Hypertension.
Pharmacy pays
From ~$0.31/30· 3 formszocor
PrescriptionFDA-sourced
Zocor (Simvastatin) is a HMG-CoA reductase inhibitor used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$0.84/30· 5 forms- Lescol XL
- Colestipol Hydrochloride
- Colestid
- Flavored Colestid
- Lopid
- Colesevelam Hydrochloride
- Lovastatin
- Atorvaliq
- Flolipid
- Lipitor
- Lipofen
- Norliqva
- Sdamlo
Frequently asked
- What treats coronary artery disease?
- Our catalog lists 19 products that may treat coronary artery disease, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is amlodipine besylate.
- What is the best-rated treatment for coronary artery disease?
- By our independent recall-safety rating — not an efficacy measure — amlodipine besylate ranks highest among the products we list for coronary artery disease. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat coronary artery disease?
- Treatments for coronary artery disease span FDA drug classes including calcium channel blocker, dihydropyridine calcium channel blocker, hmg-coa reductase inhibitor, peroxisome proliferator receptor alpha agonist, bile acid sequestrant. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Coronary Artery Disease — MedlinePlus (U.S. National Library of Medicine) ↗
- Coronary Heart Disease — National Heart, Lung, and Blood Institute (NIH) ↗
- Coronary Artery Disease — StatPearls, NCBI Bookshelf ↗
- The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (PMC) ↗